Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
about
Pneumococcal conjugate vaccines for preventing otitis mediaGenome annotation and intraviral interactome for the Streptococcus pneumoniae virulent phage Dp-1A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cellsPneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 VaccinationProtective activity of Streptococcus pneumoniae Spr1875 protein fragments identified using a phage displayed genomic libraryA current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United StaChanging epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United StatesThe role of vaccination in preventing pneumococcal disease in adultsPneumococcal capsular polysaccharide structure predicts serotype prevalenceStreptococcus pneumoniae Cell-Wall-Localized Phosphoenolpyruvate Protein Phosphotransferase Can Function as an Adhesin: Identification of Its Host Target Molecules and Evaluation of Its Potential as a VaccineMaternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspringAdhesion and invasion of Streptococcus pneumoniae to primary and secondary respiratory epithelial cellsPopulation structure of invasive Streptococcus pneumoniae isolates among Alaskan children in the conjugate vaccine era, 2001 to 2013.Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--Alaska, 2008-2012.Molecular epidemiology of serotype 19A Streptococcus pneumoniae among invasive isolates from Alaska, 1986-2010Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USAGenetic characterisation of Malawian pneumococci prior to the roll-out of the PCV13 vaccine using a high-throughput whole genome sequencing approachEpidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010.Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric radiologically confirmed community acquired pneumonia following PCV7 introduction in Switzerland.Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.Clustering of serotypes in a longitudinal study of Streptococcus pneumoniae carriage in three day care centres.Diversity of pneumococcal surface protein A (PspA) among prevalent clones in SpainPneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort studySelf-reported pediatricians' management of the well-appearing young child with fever without a source: first survey in an European country in the anti-pneumococcal vaccine era.Genetic diversity of the pneumococcal capsule: implications for molecular-based serotyping.Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.Between-strain competition in acquisition and clearance of pneumococcal carriage--epidemiologic evidence from a longitudinal study of day-care children.Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages.Epidemiological profile of meningococcal disease in the United StatesSerotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothersImmunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway.Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005Pneumococcal meningitis: clinical outcomes in a pre-vaccine era at a Dublin paediatric hospital, 1999-2007.Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccineAboriginal and non-Aboriginal children in Western Australia carry different serotypes of pneumococci with different antimicrobial susceptibility profiles.
P2860
Q24241287-E2E19C7D-5CFD-47F4-AE95-9EE761E19B37Q24600699-E51DAF5F-4099-49CB-8AA3-83F830940C27Q24651147-9A002C5F-593D-40D9-AA9B-A16153E970A0Q26739685-08335008-83A7-4481-9057-8F75980E9DB2Q27303501-7688EB8A-33B9-4100-8B86-81EBD28CA31CQ28085452-B5FCFE86-0DAE-47FD-B998-B5868A4460A9Q28277609-7C8C3F1B-6708-48E4-ACAC-3D50BDC66E83Q28396749-F23E975C-2C89-4C9C-ACCB-923A34DCC64AQ28475595-FAFFFFAE-4552-42ED-A704-A7F752A66057Q28550871-76D106D2-BD27-4749-83F4-6C6D5FCB4382Q28743311-B9AF04E5-99E4-4888-ADA4-3AAEB654E40DQ29247863-0A266E3A-857D-494D-B4D6-9066207EB185Q30151859-D2B23D6C-9BE5-452C-A8A6-D27B8584061BQ30218803-974DA09C-C35A-4EC7-BA48-06EAD9C39AAAQ30220968-CB26BAB6-AC5C-4E2C-B555-6F14CFBA6E5CQ30412578-5AB041B7-4CDD-425B-8AF6-B2A0D920DCE3Q30421183-787AB811-0A7F-4BD6-9F69-7FA42EC527F4Q30431534-36B0AC79-987E-4137-A608-CFB3C9A1A140Q31063000-19A67256-23BA-468A-BB3B-2BD3D7E30FCFQ31125433-DE609D00-FCBD-453A-85F6-F3ED6473971AQ33306103-74B971EA-3689-4D71-BBB5-1F408FD2625CQ33396556-E313F0F6-45A8-4B44-BA09-BF96E5D6FB6BQ33439975-B3D2621B-F737-4607-B74B-40EE9FA9FB35Q33452537-7C2A1A68-E6C7-4CB9-AA7E-91EDD277EC6AQ33494765-427E0699-3858-4291-8518-0989A628B846Q33499040-6F48839C-8B46-4129-BA69-3FB0EA2B3380Q33528283-985A824A-F471-4D96-A004-BB1D3864BF4AQ33551026-15669CFC-3913-4AF1-8E35-7FCE61808904Q33566530-E3C5B120-090B-4EF9-AFB8-928938D3708FQ33614101-5DB7E7DF-41BC-4531-9A32-8D927028CAF8Q33614214-E0AE52CE-22E1-4D69-B19E-835FB3AA4C20Q33648635-DD765581-124B-46AC-943F-45708C8085DAQ33653107-C895F5C0-6D22-4A9D-A48E-5DC16D2BE4E0Q33725174-B7A0AB12-D86F-48B8-AD5F-3F1E395C4A6BQ33725192-FA2715E8-6C9F-44E9-A707-56A61B80196BQ33725199-D685F789-8B48-4635-82EA-81A70632B1BDQ33729202-B77C08D1-C663-43C6-8A90-2F08690F55CFQ33745369-DEA620CC-711A-498A-BEA1-F6743AC672DBQ33777082-CDBA95CC-934F-4A23-9D6D-EA5EF99FEC7CQ33801670-F5A7F0B2-0DAB-46FE-B837-B2F8AB93E8A0
P2860
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Incidence of pneumococcal dise ...... d PCV7 vaccination, 1998-2004.
@en
type
label
Incidence of pneumococcal dise ...... d PCV7 vaccination, 1998-2004.
@en
prefLabel
Incidence of pneumococcal dise ...... d PCV7 vaccination, 1998-2004.
@en
P2093
P356
P1476
Incidence of pneumococcal dise ...... d PCV7 vaccination, 1998-2004.
@en
P2093
Allen S Craig
Ann Thomas
Arthur Reingold
Bernard Beall
Brendan Flannery
Cynthia G Whitney
Delois Jackson
James L Hadler
Lauri A Hicks
Lee H Harrison
P304
P356
10.1086/521626
P407
P577
2007-10-04T00:00:00Z